Remove 3D Remove Biotech Remove Machine Learning Remove Testing
article thumbnail

Charm Therapeutics applies AI to complex protein interactions, locking down $50M A round

TechCrunch

The world of AI-powered drug discovery keeps expanding as the capabilities of machine learning grow. “This is done most easily when one knows how exactly these drugs bind to the protein (the exact 3D shape of the ligand bound to the disease-causing protein). All it takes is one hit and they’re laughing.

article thumbnail

Prellis Biologics raises $14.5M, debuts a ‘human immune system’ in a dish

TechCrunch

Prellis Biologics , a company developing the tools to create 3D-printed organs, announced a $14.5 Up until this point, Prellis has focused on 3D printing vascular scaffolds that would allow companies to grow healthy and oxygenated human organs (or miniature versions, called organoids) for drug testing, and eventually transplant.

System 203
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Femtech Startups are booming

Apiumhub

No more temperature testing or counting days. Instead of finding out your most fertile days by taking your temperature, with Inne you do a saliva test. It uses machine learning and bioinformatics to analyse and predict vaginal microbiomes’ impact on female fertility. The startup has raised €8.8m

article thumbnail

The MedTech industry: Facts, Figures & Startups

Apiumhub

Medical technology or MedTech may include medical devices, information technology, biotech, and healthcare services. When looking specifically at the MedTech industry, 3D printing has quickly become one of the most popular technologies for new startups as well as established corporations. 3-D Printing. PredictImmune.

article thumbnail

AI in Drug Discovery and Repurposing: Benefits, Approaches, and Use Cases

Altexsoft

The study involves numerous tests in laboratories and on animals but no people are engaged. To understand whether a particular target is sensitive to medicine, scientists perform tests on cells, tissues, and animal models. Phase one aims at testing drug safety and dosage on 20 to 100 volunteers. Drug discovery process.